Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 1/20 | 0.43 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.43 |
| ▸ | ITGAV | P06756 | 1/20 | 0.43 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.43 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.39 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18796727 | 1.00 | ITGB3 (0.43) | ITGB3ITGB1ITGAVITGA4FKBP5 | |
| SCHEMBL13545399 | 0.98 | ITGB3 (0.42) | ITGB3ITGB1ITGAVITGA4FKBP5 | |
| SCHEMBL16107849 | 0.93 | — | — | |
| SCHEMBL12963772 | 0.93 | — | — | |
| SCHEMBL16107526 | 0.93 | — | — | |
| SCHEMBL22435208 | 0.84 | FKBP5 (0.34) | ITGB3ITGB1ITGAVITGA4FKBP5 | |
| SCHEMBL11722783 | 0.81 | FKBP5 (0.38) | FKBP5CRBNOR51E2 | |
| SCHEMBL7989075 | 0.81 | FKBP5 (0.38) | FKBP5CRBNOR51E2 | |
| SCHEMBL11727451 | 0.79 | FKBP5 (0.37) | FKBP5CRBNNPC1HPGDRAB9A | |
| SCHEMBL22435286 | 0.78 | OR51E2 (0.32) | ITGB3ITGB1ITGAVITGA4OR51E2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111868031-B | Process for the preparation of N-alkoxycarbonylpiperidine derivatives and intermediates therefor | 有机合成药品工业株式会社 | 2023-10-03 | — | — | CN | claimed |
| EP-1400511-B1 | Methods of producing n-alkoxycarbonylpiperidine derivatives and intermediates therefor | YUKI GOSEI YAKUHIN KOGYO KK (JP) | 2008-09-03 | — | — | EP | claimed |
| US-6900326-B2 | Method of producing N-alkoxycarbonylpiperidine derivative, new compound as raw material therefor, and method of producing the compound | YUKI GOSEI KOGYO CO., LTD. (JP) | 2005-05-31 | — | — | US | claimed |
| US-20040063953-A1 | Method of producing N-alkoxycarbonylpiperidine derivative, new compound as raw material therefor, and method of producing the compound | YUKI GOSEI KOGYO CO., LTD. (JP) | 2004-04-01 | — | — | US | claimed |
| EP-1400511-A1 | Methods of producing n-alkoxycarbonylpiperidine derivatives and intermediates therefor | YUKI GOSEI KOGYO CO., LTD. (JP) | 2004-03-24 | — | — | EP | claimed |
| CN-111868031-B | Process for the preparation of N-alkoxycarbonylpiperidine derivatives and intermediates therefor | 有机合成药品工业株式会社 | 2023-10-03 | — | — | CN | disclosed |
| CN-111868031-A | Process for producing N-alkoxycarbonylpiperidine derivative and intermediate therefor | 有机合成药品工业株式会社 | 2020-10-30 | — | — | CN | disclosed |
| WO-2019142900-A1 | METHOD FOR PRODUCING N-ALKOXYCARBONYLPIPERIDINE DERIVATIVE, AND INTERMEDIATE THEREFOR | 有機合成薬品工業株式会社 | 2019-07-25 | — | — | WO | disclosed |
| WO-2018021977-A1 | GLYCINE METABOLISM MODULATORS AND USES THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2018-02-01 | — | — | WO | disclosed |
| WO-2017072796-A1 | 2-PYRIDONE BASED COMPOUNDS USEFUL AS POTENTIAL PHOSPHODIESTERASE3A (PDE3A)INHIBITORS AND A PROCESS FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2017-05-04 | — | — | WO | disclosed |
| CN-102949357-B | A kind of tablet of prasugrel hydrobromide | SHANDONG NEW TIME PHARMACEUTICAL Co.,Ltd. (CN) | 2016-01-27 | — | — | CN | disclosed |
| CN-104173316-A | Capsule of hydrobromic acid prasugrel | SHANGDONG NEW TIME PHARM PROD | 2014-12-03 | — | — | CN | disclosed |
| CN-102949357-A | Prasugrel hydrobromide tablet | SHANGDONG NEW TIME PHARM PROD | 2013-03-06 | — | — | CN | disclosed |
| EP-1400511-B1 | Methods of producing n-alkoxycarbonylpiperidine derivatives and intermediates therefor | YUKI GOSEI YAKUHIN KOGYO KK (JP) | 2008-09-03 | — | — | EP | disclosed |
| WO-2008059862-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE 2-(2'-PIPERIDINYL)ACETATE | UBE INDUSTRIES, LTD. (JP) | 2008-05-22 | — | — | WO | disclosed |
| US-6900326-B2 | Method of producing N-alkoxycarbonylpiperidine derivative, new compound as raw material therefor, and method of producing the compound | YUKI GOSEI KOGYO CO., LTD. (JP) | 2005-05-31 | — | — | US | disclosed |
| US-20040063953-A1 | Method of producing N-alkoxycarbonylpiperidine derivative, new compound as raw material therefor, and method of producing the compound | YUKI GOSEI KOGYO CO., LTD. (JP) | 2004-04-01 | — | — | US | disclosed |
| EP-1400511-A1 | Methods of producing n-alkoxycarbonylpiperidine derivatives and intermediates therefor | YUKI GOSEI KOGYO CO., LTD. (JP) | 2004-03-24 | — | — | EP | disclosed |
| WO-1999029705-A9 | SIALYL LEWIS X AND SIALYL LEWIS A GLYCOMIMETICS | GLYCOMED INC (US) | 1999-11-11 | — | — | WO | disclosed |
| WO-1999029705-A2 | SIALYL LEWIS X AND SIALYL LEWIS A GLYCOMIMETICS | GLYCOMED INCORPORATED (US) | 1999-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063953-A1 | Method of producing N-alkoxycarbonylpiperidine derivative, new compound as raw material therefor, and method of producing the compound | ORMDL3, MRPS18A, ACSL3 | ITGB3 2625/4885ITGB1 1375/4885ITGAV 856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.